z-logo
open-access-imgOpen Access
Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19
Author(s) -
Matthew G. Johnson,
Amy Puenpatom,
Pablo Andrés Moncada,
Lesley Burgess,
Elizabeth R Duke,
Norio Ohmagari,
Timo Wolf,
Matteo Bassetti,
Sanjay Bhagani,
Jade Ghosn,
Ying Zhang,
Hong Wan,
Angela Williams-Diaz,
Michelle Brown,
Amanda Paschke,
Carisa De Anda
Publication year - 2022
Publication title -
annals of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.839
H-Index - 390
eISSN - 1539-3704
pISSN - 0003-4819
DOI - 10.7326/m22-0729
Subject(s) - medicine , covid-19 , psychological intervention , respiratory system , intensive care medicine , betacoronavirus , virology , disease , infectious disease (medical specialty) , outbreak , nursing
In the MOVe-OUT trial, molnupiravir showed a clinically meaningful reduction in the risk for hospitalization or death in adults with mild to moderate COVID-19 and risk factors for progression to severe disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here